Fouad MA

References (3)

Title : Design, synthesis, in vitro, and in vivo evaluation of novel phthalazinone-based derivatives as promising acetylcholinesterase inhibitors for treatment of Alzheimer's disease - Ezzat_2023_Drug.Dev.Res__
Author(s) : Ezzat MAF , Abdelhamid SM , Fouad MA , Abdel-Aziz HA , Allam HA
Ref : Drug Dev Res , : , 2023
Abstract :
PubMedSearch : Ezzat_2023_Drug.Dev.Res__
PubMedID: 37243322

Title : Dual-target ligand discovery for Alzheimer's disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and beta-amyloid aggregation - El-Hussieny_2023_J.Enzyme.Inhib.Med.Chem_38_2166040
Author(s) : El-Hussieny M , Abd-El-Maksoud MA , Soliman FM , Fouad MA , El-Ashrey MK
Ref : J Enzyme Inhib Med Chem , 38 :2166040 , 2023
Abstract :
PubMedSearch : El-Hussieny_2023_J.Enzyme.Inhib.Med.Chem_38_2166040
PubMedID: 36695002

Title : New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and beta-Amyloid aggregation for treatment of Alzheimer's disease - El-Sayed_2019_Bioorg.Chem_95_103499
Author(s) : El-Sayed NF , El-Hussieny M , Ewies EF , Fouad MA , Boulos LS
Ref : Bioorg Chem , 95 :103499 , 2019
Abstract :
PubMedSearch : El-Sayed_2019_Bioorg.Chem_95_103499
PubMedID: 31838287